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The liver is a unique organ with an extraordinary capacity to regenerate upon various injuries. In acute and transient
liver injury by insults such as chemical hepatotoxins, the liver in rodents returns to the original architecture by
proliferation and remodeling of the remaining cells within a week. In contrast, chronic liver inflammation due to
various etiologies, e.g., virus infection and metabolic and immune disorders, results in liver fibrosis, often leading
to cirrhosis and carcinogenesis. In both acute and chronic inflammation, a variety of immune and non-immune
cells in the liver is involved in the processes resulting in either regeneration or fibrosis. In addition, chronic
hepatitis often accompanies proliferation of atypical biliary cells, also known as liver progenitor cells or oval cells.
Although the origin of liver progenitor cells and its contribution to hepatic repair is still under intense debate,
recent studies have revealed a regulatory role for immune cells in progenitor proliferation and differentiation. In
this review, we summarize recent studies on liver regeneration and fibrosis in the viewpoint of inflammation.
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The liver is a central organ for homeostasis and carries
out a wide variety of functions, including metabolism,
glycogen storage, drug detoxification, production of
various serum proteins, and bile secretion. Most of
those liver functions are carried out by hepatocytes,
the liver parenchymal cells, which account for ap-
proximately 60 % of total liver cells and 80 % of the
total liver volume. Hepatocytes are highly polarized
epithelial cells and form cords (Fig. 1). Their basolat-
eral surfaces face the sinusoid, a unique form of capil-
lary in the liver, which consists of fenestrated liver
sinusoidal endothelial cells (LSECs) and hepatic stel-
late cells (HSCs). Tight junctions formed between
hepatocytes create a canaliculus surrounded by the
apical membrane of neighboring hepatocytes. Bile se-
creted from hepatocytes is exported sequentially
through the bile canaliculi, intrahepatic bile ducts, ex-
trahepatic bile ducts, and finally into the duodenum.
The bile duct is formed by another type of epithelial
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common progenitor, “hepatoblast,” during develop-
ment [1]. In the similar context of liver progenitors,
the adult liver also harbors a specialized type of cells
which proliferates clonally in vitro and gives rise to
hepatocyte and BEC depending on culture conditions
[2, 3]. It has been believed that such a tissue stem cell-
like progenitor contributes to hepatic repair in a case
of emergency, e.g., severe or chronic liver injury. How-
ever, whether and where stem cells exist in the adult
liver is still under debate.
Historically, the regenerative capacity of the liver is
well known, and the mechanisms underlying liver regen-
eration have been investigated for many years. In 1931,
Higgins and Anderson developed an experimental model
of liver regeneration, i.e., surgical removal of rat median
and left lobes that correspond to two thirds of the total
liver mass [4]. Since then, the two-thirds partial hepatec-
tomy (PHx) has been used as a standard model for liver
regeneration. In this model, the remnant liver lobes en-
large to compensate for the lost mass, which is known
as compensatory hyperplasia. After decades of studies
on the liver regeneration from two-thirds PHx, it was
believed that one or two replications of the remaining
hepatocytes should be empirically sufficient to recoverle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Fig. 1 Schematic overview of the hepatic lobule. Blood flows into the liver from the portal vein and the hepatic artery toward the central vein
through the sinusoid surrounded by fenestrated liver sinusoidal endothelial cells (LSECs). Bile produced by hepatocytes is collected into the bile
ducts via the bile canaliculi surrounded by the apical membrane of hepatocytes. Kupffer cells (KC), resident macrophages in the liver, are located
at the luminal side of the sinusoids, while hepatic stellate cells (HSCs) are positioned in close proximity to LSECs. The canals of Hering is the joint
between hepatocytes and the bile ducts
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old theme by using modern techniques revealed that
“hypertrophy” of hepatocytes precedes proliferation and
that hypertrophy and proliferation contribute almost
equally to the recovery of liver mass [5]. While PHx is
an excellent model to study the process of compensatory
growth of the liver and provides useful information rele-
vant to liver transplantation, it does not faithfully recapitu-
late repair processes in human pathological conditions of
liver diseases caused by virus infection, metabolic and
immune disorders, drug intoxication, and so on. Here,
we describe the cellular basis of liver regeneration and
fibrosis after inflammation in acute and chronic liver
injuries.
Main text
Metabolic zonation, drug-induced acute liver injury,
and regeneration
The functional liver unit consists of the hepatic lobule,
which has a central vein and hexagonal or polygonal
portal triads consisting of the portal vein, hepatic ar-
tery, and bile duct. The central vein is connected to
portal triads via sinusoids that run through the hepatic
plates. Although all hepatocytes are morphologicallysimilar, their functions are quite diverse and determined
by their location along the porto-central axis of the func-
tional liver unit, the hepatic lobule. Periportal hepatocytes
are specialized for oxidative liver functions such as gluco-
neogenesis, ß-oxidation of fatty acids, and cholesterol syn-
thesis, while pericentral hepatocytes are more important
for glycolysis, lipogenesis, and cytochrome P450-based
drug detoxification. Metabolic zonation is formed by a
Wnt/ß-catenin signaling gradient [6, 7]. A recent study
revealed that LGR4/5 receptors and their cognate
RSPO ligands potentiate Wnt/ß-catenin signaling and
control liver zonation [8].
Centrilobular hepatocytes express cytochrome P450s
(Cyps) abundantly, which metabolize alcohol and various
chemical hepatotoxins such as acetaminophen, carbon
tetrachloride (CCl4), and thioacetamide, to generate highly
reactive free radicals that damage hepatocytes. A single
administration of drugs such as CCl4 induces necrosis of
hepatocytes and disorganization of sinusoids surrounding
the central vein. Proliferation of hepatocytes starts within
24 h, peaks at around 48 h, and terminates by 72 h in mice
[9]. Along with proliferation of hepatocytes, sinusoid
remodeling occurs in the necrotic area. Prior to these
responses, hepatocytes damaged by free radicals produce
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inflammation, by which the activated non-parenchymal
cells contribute to regeneration. The resident and the
recruited inflammatory cells from the bone marrow
play a crucial role in regeneration and remodeling at
the damaged area. The activated Kupffer cell, a resi-
dent hepatic macrophage, secretes interleukin-6 (IL-6)
that directly induces hepatic expression of multiple
genes associated with acute phase proteins, cell-cycle,
redox, and anti-apoptosis to facilitate the proliferation
of remnant hepatocytes [9–11]. HSCs and LSECs also
play crucial roles in the proliferation of hepatocyte and
sinusoidal remodeling after liver injury. The HSCs
stimulated by inflammation contribute to the initiation
of liver regeneration by secreting hepatocyte growth
factor (HGF). In addition, the activated HSCs start to
produce extracellular matrix (ECM) including colla-
gens to fix the architecture of injured tissue in a simi-
lar manner to the process of wound healing [12, 13].
The ECM serves as a scaffold for the proliferation of
hepatocytes and maintains the mechanical stability in
the damaged region. The LSECs activated by acute in-
flammation also secrete HGF and Wnt2 to promote
liver regeneration [14]. We have reported that Sema3e
produced by damaged hepatocytes induces contraction
of LSECs, which supports the activation of HSCs and
the infiltration of leukocytes into the damaged area
[15]. Given that insult of the liver is transient, these
cells activated by inflammation will be eventually settled,
followed by the resolution of ECM and revascularization.
Thus, activation of non-parenchymal cells in the injured
area and proliferation of undamaged hepatocytes must be
well orchestrated to restore the original mass, functions,
and structure of the liver in acute inflammation.
Chronic liver injury and fibrosis
Chronic inflammation is an immune response that
persists for months, in which inflammation and tissue
remodeling and repair processes occur simultaneously.
It can be induced by a number of different insults
including hepatitis virus infection, excessive alcohol
intake, autoimmune reactions, toxins, and metabolic
disorders. However, regardless of etiology, chronic in-
flammation induces fibrosis that eventually leads to
cirrhosis and hepatocellular carcinoma. In chronic
hepatitis, activated HSCs become myofibroblasts and
play a dominant role in fibrosis by producing a large
amount of collagen. In addition, upregulation of a tis-
sue inhibitor of metalloproteinases-1 (TIMP-1) in the
fibrotic liver contribute to collagen deposition by inhi-
biting the resolution of ECM. Persistent production of
growth factors for HSCs, fibrogenic cytokines, and
chemokines by various types of liver cells are involved
in fibrogenesis in chronic inflammation. Among those,TGF-ß produced by immune cells directly promotes
fibrogenesis by inducing the transcription of type I
and III collagen through the Smad signaling pathway
[16]. IL-1ß and TNF-α do not induce HSC activation
instead mediate the survival of activated HSCs and
thereby contribute to liver fibrosis [17]. A recent study
has revealed the implication of IL-33, an IL-1 family
member cytokine in liver fibrosis. IL-33 secreted from
damaged hepatocytes stimulates type 2 innate lymphoid
cells (ILC2) to produce IL-13, which in turn promotes the
activation of HSCs through STAT6 activation [18].
Chemokines also play a role in liver fibrosis via non-
immune cells as well as immune cells in the liver. Two
types of receptors for CXCL12 (also called SDF1),
CXCR4 and CXCR7, regulate a balance between regen-
eration and fibrosis after liver injury through the pheno-
typic change of hepatic vascular niche [14]. CXCR4 and
CXCR7 are differentially expressed in LSECs depending
on the condition of the damaged liver, and CXCR7 up-
regulation after acute injury contributes to liver regen-
eration by deploying pro-regenerative factors such as
Wnt2 and HGF through the induction of transcription
factor Id1. In contrast, constitutive FGFR1 signaling in
LSEC under chronic hepatitis induces the predomin-
ance of CXCR4 over CXCR7 by augmenting CXCR4
expression, leading to a shift from pro-regenerative vas-
cular niche to pro-fibrotic phenotype accompanied by
the proliferation of activated HSCs. On the other hand,
CCL2, also called MCP-1 secreted from Kupffer cell
and HSC, contributes to the recruitment of CCR2+
Ly6C+ monocytes into the liver. The recruited Ly6Chi
macrophages are pro-inflammatory and pro-fibrotic
and produce IL-1ß, TNF-α, TGF-ß, and PDGF to in-
duce the survival, activation, and proliferation of myofi-
broblasts [19–22]. As such, hepatic macrophages
contribute to liver fibrogenesis, while they play a crucial
role in the resolution of ECM [23]. Ly6Clo restorative
macrophages have been reported to exhibit pro-
resolution phenotypes with increased expression of
fibrinolytic matrix metalloproteinases (MMPs) includ-
ing MMP9 and MMP12, phagocytosis-related genes,
and growth factors [20]. Thus, after acute inflamma-
tion, the phenotypic switch of pro-inflammatory macro-
phages to restorative macrophages together with the
disappearance of pro-fibrotic macrophages plays im-
portant roles in liver regeneration and ECM resorption.
Thus, interactions among immune and non-immune
cells in response to persistent inflammatory factors can
be a fork toward hepatic regeneration or fibrosis in
chronic hepatitis (Fig. 2).
Liver stem/progenitor cells and ductular reaction
Hepatocytes have a long lifespan, and new hepatocytes
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Fig. 2 Phenotypic changes of non-parenchymal cells associated with liver regeneration or fibrosis after injury
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to require a resident stem cell population. Also, in acute
liver injury, because remnant hepatocytes proliferate to
restore the lost cells, stem cells are not necessarily
needed. However, in chronic liver injury, it has been be-
lieved that liver progenitor cells (LPCs) or oval cells con-
tribute to liver regeneration. Fundamentally, LPCs are
defined as bi-potential cells similar to fetal hepatoblast,
which can differentiate to both hepatocytes and BECs
[1]. Chronic liver injuries often accompany “ductular re-
action,” which is histologically characterized as ectopic
emergence and expansion of bile duct marker-positive
cells around the portal vein. It has long been postulated
that ductular reaction represents the activation of adult
LPCs that may reside in the biliary tree or the canals of
Hering, the junctional structure connecting hepatocytes
and the bile ducts. The concept of LPCs has been a
paradigm in liver regeneration upon chronic injury, and
most studies have focused on whether and how LPCs
can proliferate and differentiate to hepatocytes to replen-
ish the lost functions of the liver. Considering that LPCs
expand in the case of chronic hepatitis, LPCs are sup-
posed to be activated in response to inflammation. Infact, implications of several inflammatory cytokines,
such as tumor necrosis factor (TNF)-alpha, interleukin-
6, and interferon-gamma, in LPC proliferation have been
reported [24–26]. Among those factors, TNF-related
WEAK inducer of apoptosis (TWEAK) and fibroblast
growth factor 7 (FGF7) are of particular interest, as they
are capable of inducing de novo activation of LPCs without
inflammatory insults, suggesting that the cell-of-origin for
LPCs is responsive to these extracellular signals [27, 28].
Other growth factors, such as HGF and EGF, have also
been implicated in regulating proliferation and/or dif-
ferentiation of LPCs [29, 30]. Notch signaling is well
known to play a pivotal role in the differentiation of
fetal hepatoblasts into BECs [31–34]. In line with this
notion, Boulter et al. reported that Jagged 1, a Notch
ligand expressed by activated myofibroblasts, promoted
the specification of LPCs to BECs during biliary regen-
eration [35]. Notably, macrophages engulfing hepato-
cyte debris expressed Wnt3a, which enhances canonical
Wnt signaling and opposes Notch signaling in LPCs to
promote their specification to hepatocytes during liver
regeneration. Thus, LPCs are apparently a “facultative”
stem/progenitor cell population that emerges around
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microenvironment generated by chronic inflammation.
A controversy issue on the role of LPC in regeneration
In sharp contrast to LPCs around the portal vein, Wang
et al. identified a population of proliferating and self-
renewing cells adjacent to the central vein by lineage
tracing using the Wnt-responsive gene Axin2 in mice
[36]. These pericentral cells expressed the early liver
progenitor marker Tbx3, are diploid, and thereby differ
from mature hepatocytes, which are mostly polyploid.
Adjacent central vein endothelial cells provide Wnt sig-
nals that maintain such pericentral cells, thereby con-
stituting the niche. The descendants of pericentral cells
differentiate into Tbx3-negative polyploid hepatocytes
and can replace all hepatocytes along the liver lobule
during homeostatic renewal, although their contribu-
tion to hepatic repair after injury remains unknown.
However, a more recent study showed that LGR4+ he-
patocytes throughout the lobule contribute to liver
homeostasis without zonal dominance, contradictory to
the pericentral stem cell [8]. Furthermore, Font-Burgada
et al. showed that there are a subset of periportal hepato-
cytes, “hybrid hepatocytes,” that express low levels of Sox9
and some bile duct-enriched genes, and it has been
claimed that hybrid hepatocytes are the cells that primar-
ily mediate liver injury repair [37].
In contrast, many recent studies employing genetic
lineage-tracing approaches in vivo have shown that
LPCs and/or pre-existing BECs do not or rarely con-
tribute to new hepatocytes in mouse models, thereby
raising a doubt on the concept that LPCs serve as the
backup for hepatocyte regeneration [38–40]. These ap-
parently contradictory results regarding the origin of
new hepatocytes in chronic liver injury may be due to
the differences in injury models employed. If healthy
hepatocytes remain in the injured liver, they proliferate
to restore normal functions, but biliary-derived LPCs
may give rise to new hepatocytes when most hepato-
cytes are severely damaged. For instance, hepatocyte-
specific genetic deletion of E3 ubiquitin ligase Mdm2
induced hepatocytes to apoptosis, necrosis, and senes-
cence in those cells. Under such severe condition, LPCs
are activated to reconstitute functional liver [41].
Lineage-tracing experiments have significantly ad-
vanced our understating on LPC and ductular reaction,
while the cell-of-origin for LPC is still under intense
debate. Using newly established imaging approaches to
capture three-dimensional (3D) tissue morphology in
situ, we have recently reported that ductular reaction
essentially represents the dynamic and adaptive changes
of ductal cells maintaining duct-like structure and con-
nection with the portal bile ducts [42]. Clonal tracing
further revealed the heterogeneity of BECs in terms ofproliferation activity in vivo and that BECs in the per-
iphery proliferate in a stochastic manner [43]. While it
remains to be shown whether there is a specific class of
BEC that functions as LPC by producing hepatocytes, it
should be noted that the BEC marker-positive cells that
emerge in chronic liver injury, which have been consid-
ered as LPC, are connected to the bile ducts.Conclusions
Liver regeneration is a well coordinated process by
hepatocytes and non-parenchymal cells. However, per-
sistent inflammation in chronic hepatitis alters the
well-ordered phenotypic changes of non-parenchymal
cells and leads to an aberrant healing process, i.e., liver
fibrosis. Along the progression of fibrosis, the replace-
ment of the damaged tissue with ECM impairs the
functions, flexible structure, and regeneration capacity
of the liver. Although the most effective therapy for
fibrosis to date is elimination of causative agents in
earlier stages, it is insufficient to restore the cirrhotic
liver to its original condition in many cases. Liver fibro-
genesis is often accompanied by the emergence of
LPCs, suggesting that fibrotic environment including
activated myofibroblasts and immune cells may serve
as a niche for proliferating LPCs. Further investigation
of regulatory mechanisms underlying liver fibrosis and
the role of LPCs in regeneration will help in developing
therapeutic strategies to counter liver disease.
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